Patents by Inventor Michael J. Brownstein

Michael J. Brownstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY
    Publication number: 20240115553
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating brain injuries.
    Type: Application
    Filed: April 17, 2023
    Publication date: April 11, 2024
    Applicant: Azevan Pharmaceuticals, Inc.
    Inventor: Michael J. BROWNSTEIN
  • COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
    Publication number: 20230123729
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.
    Type: Application
    Filed: April 29, 2022
    Publication date: April 20, 2023
    Inventor: Michael J. BROWNSTEIN
  • Compositions and methods for treating brain injury
    Patent number: 11628160
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating brain injuries.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: April 18, 2023
    Assignee: Azevan Pharmaceuticals, Inc.
    Inventor: Michael J. Brownstein
  • Compositions and methods for treating neurodegenerative diseases
    Patent number: 11319306
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: May 3, 2022
    Assignee: Azevan Pharmaceuticals, Inc.
    Inventor: Michael J. Brownstein
  • Methods for treating post traumatic stress disorder
    Patent number: 10953001
    Abstract: Compounds and compositions are described herein for treating post traumatic stress disorder.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: March 23, 2021
    Assignee: Azevan Pharmaceuticals, Inc.
    Inventor: Michael J. Brownstein
  • COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY
    Publication number: 20200276167
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating brain injuries.
    Type: Application
    Filed: September 17, 2018
    Publication date: September 3, 2020
    Inventor: Michael J. BROWNSTEIN
  • COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
    Publication number: 20200102294
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.
    Type: Application
    Filed: June 10, 2019
    Publication date: April 2, 2020
    Inventor: Michael J. BROWNSTEIN
  • Compositions and methods for treating neurodegenerative diseases
    Patent number: 10364236
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: July 30, 2019
    Assignee: Azevan Pharmaceuticals, Inc.
    Inventor: Michael J. Brownstein
  • METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER
    Publication number: 20190099410
    Abstract: Compounds and compositions are described herein for treating post traumatic stress disorder.
    Type: Application
    Filed: May 23, 2018
    Publication date: April 4, 2019
    Inventor: Michael J. BROWNSTEIN
  • COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
    Publication number: 20180201608
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.
    Type: Application
    Filed: October 18, 2017
    Publication date: July 19, 2018
    Inventor: Michael J. BROWNSTEIN
  • Methods for treating post traumatic stress disorder
    Patent number: 9987265
    Abstract: Compounds and compositions are described herein for treating post traumatic stress disorder.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: June 5, 2018
    Assignee: AZEVAN PHARMACEUTICALS, INC.
    Inventor: Michael J. Brownstein
  • Compositions and methods for treating neurodegenerative diseases
    Patent number: 9802925
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: October 31, 2017
    Assignee: AZEVAN PHARMACEUTICALS, INC.
    Inventor: Michael J. Brownstein
  • Malignant and non-malignant disease treatment with Ras antagonists
    Patent number: 9738614
    Abstract: The present disclosure describes new inhibitors or antagonists of Ras useful for the treatment of conditions resulting from Ras-induced or mediated cellular processes, including cellular proliferation, differentiation, apoptosis, senescence, and survival. These cellular processes may be associated with a non-malignant or malignant disease, disorder, or pathological condition. The present disclosure also describes a method for inhibiting such Ras-induced or mediated cellular processes. The method entails administering a Ras antagonist in an amount effective to inhibit such cellular processes.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: August 22, 2017
    Assignee: Pisces Therapeutics, LLC
    Inventors: James H. Wikel, Michael J. Brownstein
  • COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
    Publication number: 20170174670
    Abstract: Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.
    Type: Application
    Filed: March 27, 2015
    Publication date: June 22, 2017
    Applicant: Azevan Pharmaceuticals, Inc.
    Inventor: Michael J. BROWNSTEIN
  • METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER
    Publication number: 20160339006
    Abstract: Compounds and compositions are described herein for treating post traumatic stress disorder.
    Type: Application
    Filed: April 21, 2016
    Publication date: November 24, 2016
    Inventor: Michael J. BROWNSTEIN
  • MALIGNANT AND NON-MALIGNANT DISEASE TREATMENT WITH RAS ANTAGONISTS
    Publication number: 20160207891
    Abstract: The present disclosure describes new inhibitors or antagonists of Ras useful for the treatment of conditions resulting from Ras-induced or mediated cellular processes, including cellular proliferation, differentiation, apoptosis, senescence, and survival. These cellular processes may be associated with a non-malignant or malignant disease, disorder, or pathological condition. The present disclosure also describes a method for inhibiting such Ras-induced or mediated cellular processes. The method entails administering a Ras antagonist in an amount effective to inhibit such cellular processes.
    Type: Application
    Filed: March 25, 2016
    Publication date: July 21, 2016
    Applicant: PISCES THERAPEUTICS, LLC
    Inventors: James H. Wikel, Michael J. Brownstein
  • Methods for treating post traumatic stress disorder
    Patent number: 9376424
    Abstract: Compounds and compositions are described herein for treating post traumatic stress disorder.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: June 28, 2016
    Assignee: AZEVAN PHARMACEUTICALS, INC.
    Inventor: Michael J. Brownstein
  • Malignant and non-malignant disease treatment with Ras antagonists
    Patent number: 9309203
    Abstract: The present disclosure describes new inhibitors or antagonists of Ras useful for the treatment of conditions resulting from Ras-induced or mediated cellular processes, including cellular proliferation, differentiation, apoptosis, senescence, and survival. These cellular processes may be associated with a non-malignant or malignant disease, disorder, or pathological condition. The present disclosure also describes a method for inhibiting such Ras-induced or mediated cellular processes. The method entails administering a Ras antagonist in an amount effective to inhibit such cellular processes.
    Type: Grant
    Filed: October 5, 2012
    Date of Patent: April 12, 2016
    Assignee: Pisces Therapeutics, LLC
    Inventors: James H. Wikel, Michael J. Brownstein
  • MALIGNANT AND NON-MALIGNANT DISEASE TREATMENT WITH RAS ANTAGONISTS
    Publication number: 20140249163
    Abstract: The present disclosure describes new inhibitors or antagonists of Ras useful for the treatment of conditions resulting from Ras-induced or mediated cellular processes, including cellular proliferation, differentiation, apoptosis, senescence, and survival. These cellular processes may be associated with a non-malignant or malignant disease, disorder, or pathological condition. The present disclosure also describes a method for inhibiting such Ras-induced or mediated cellular processes. The method entails administering a Ras antagonist in an amount effective to inhibit such cellular processes.
    Type: Application
    Filed: October 5, 2012
    Publication date: September 4, 2014
    Applicant: PICES THERAPEUTICS LLC
    Inventors: James H. Wikel, Michael J. Brownstein
  • METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER
    Publication number: 20130109666
    Abstract: Compounds and compositions are described herein for treating post traumatic stress disorder.
    Type: Application
    Filed: July 1, 2011
    Publication date: May 2, 2013
    Applicant: AZEVAN PHARMACEUTICALS, INC.
    Inventor: Michael J. Brownstein